Investing Profile

Karl Handelsman(204)

CEO
Founder & Investor at Codon Capital
codoncapital.com/about.htmlSan Francisco, California
Photo of Karl Handelsman, Investor at Codon Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

9 Investors

Connected to Dror Berman (Innovation Endeavors), Zach Coelius (Coelius Capital), Brian Frank (FTW Ventures), and 6 other investors on Signal.

Stanford University Network
186 CONNECTIONS
Genentech Network
31 CONNECTIONS
cb
Codon Capital Investor
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Bonum Therapeutics
Series ANov 2022$93M
$93M
Co-investors: John McKearn (RiverVest), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Good Therapeutics
Series AFeb 2019$11M
$30M
Co-investors: John McKearn (RiverVest), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Clear Labs
Series BOct 2018$21M
$170M
Co-investors: Aydin Senkut (Felicis Ventures), Krishna Yeshwant (GV (Google Ventures)), Greg Yap (Menlo Ventures), Chris Sklarin (Alumni Ventures ), Miguel Valls (Alta Life Sciences), Kyle Kurpinski (Tencent Holdings)
Member Life Science Angels2014 - Present
Catalyst Advisory Panel UCSF2013 - Present
SPARK Selection Committee Stanford University2013 - Present
Founder & Investor Codon Capital2013 - Present
Senior Advisor, Roche Venture Fund Genentech2016 - 2021
Mentor California Inst. for Regenerative Medicine2013 - 2016
Lean Launchpad for Therapeutics/Tools Instructor UCSF2013 - 2016
General Partner Emeritus CMEA Capital2013 - 2014
Managing Director/General Partner CMEA Capital1999 - 2013
Director, Business Development Millennium Pharmaceuticals1996 - 1997
Manager, Business Development Tularik1992 - 1996